Feedback PLC Notice of Results, Analyst & Investor Presentation (3015M)
January 11 2023 - 2:00AM
UK Regulatory
TIDMFDBK
RNS Number : 3015M
Feedback PLC
11 January 2023
Feedback plc
Notice of Results & Investor Presentation
Feedback plc (AIM: FDBK, "Feedback" or the "Company"), the
frontline clinical technology company, will announce results for
the half year ended 30 November 2022 on Tuesday 07 February
2023.
Analyst Presentation: 11:00 am, Tuesday 07 February
A remote briefing for analysts will be held at 11.00am on the
morning of the results. Analysts interested in attending should
contact Walbrook PR on feedbackplc@walbrookpr.com or 020 7933
8780.
Investor Presentation: 4:00pm, Tuesday 07 February
Management will be providing a presentation and hosting an
investor Q&A session on the Company's results and future
prospects on Tuesday 07 February at 4:00pm. Investors can sign up
for free and register to meet FDBK via the following link:
https://www.investormeetcompany.com/feedback-plc/register-investor
Investors who have already registered on the Investor Meet
Company platform to meet the Company will automatically be
invited.
-Ends-
Enquiries:
Feedback plc +44 (0) 20 3997 7634
Tom Oakley, CEO IR@fbk.com
Anesh Patel, CFO
Panmure Gordon (UK) Limited
(NOMAD and Broker)
Emma Earl/Freddy Crossley (Corporate
Finance)
Rupert Dearden (Corporate Broking) +44 (0)20 7886 2500
Walbrook PR Ltd; Tel: 020 7933 8780 or feedbackplc@walbrookpr.com
Nick Rome/Joe Walker 07748 325 236 or 07407 020 470
About Feedback
Feedback plc helps clinical teams to make better decisions
faster for patients. We design products that enhance clinician
access to patient data and to their colleagues. Our unique approach
centres around individual patient episodes, into which we pull
relevant clinical data from hospital systems and around which we
build remote clinical teams for collaboration. As a result, we
produce a digital infrastructure that makes patient data available
to clinicians in multiple settings, in a format that enables them
to meaningfully interact with it, providing flexibility to
clinicians and free movement of patients between provider settings
- clinicians can practice from anywhere and patients can attend any
care provider for treatment.
Our products Bleepa and CareLocker work together to deliver
unparalleled value to our customers. Bleepa is our application
layer and sits on top of CareLocker as our data layer. Bleepa is a
clinician facing platform that displays clinical results from a
patient's CareLocker at a certified and regulated quality, that is
suitable for clinical use and enables dialogue on a
patient-by-patient basis with colleagues through a secure,
auditable chat interface that links back to the patient medical
record. The CareLocker data storage model is built around the
patient. Our vision is one where relevant clinical data is always
available to the patient as well as to any care setting that they
may attend - a federated data architecture with the patient as the
tenant.
The Company has a number of growth opportunities domestically
and internationally across a range of markets including the NHS,
the veterinary market and private healthcare providers and its
highly scalable Software as a Service ("SaaS")-based revenue model
is expected to provide increasing levels of visibility as the
Company grows its customer base.
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our Privacy
Policy.
END
NORNKKBDOBKDPDD
(END) Dow Jones Newswires
January 11, 2023 02:00 ET (07:00 GMT)
Feedback (LSE:FDBK)
Historical Stock Chart
From Jul 2024 to Jul 2024
Feedback (LSE:FDBK)
Historical Stock Chart
From Jul 2023 to Jul 2024